Le Lézard
Classified in: Health
Subject: SVY

LexisNexis Risk Solutions Addresses Medication Non-compliance through New Predictive Score


ATLANTA, Sept. 19, 2019 /PRNewswire/ -- LexisNexis® Risk Solutions has released a Socioeconomic Health Score that will provide insights on medication adherence for patients on a prescription maintenance regimens. Part of the company's suite of social determinants of health (SDOH) solutions, the score predicts an individual's medication adherence rate over 12 months with the goal of decreasing non-compliance.

LexisNexis Risk Solutions Health Care. (PRNewsfoto/LexisNexis Risk Solutions)

"By identifying patients at the highest risk of failing to follow their medication protocol, pharmacies, payers, providers and other organizations entering into value-based agreements can take proactive steps to help them stay compliant and achieve optimal health outcomes," says Josh Schoeller, senior vice president and general manager, LexisNexis Risk Solutions.

LexisNexis Risk Solutions data scientists analyze environmental, economic and community attributes to identify factors, that when addressed, will lead to patients adhering to their medication regimens. All attributes used in the predictive score are clinically validated against health outcomes and help deliver the appropriate care interventions even when little to no traditional clinical data is available. LexisNexis Risk Solutions discovered the following insights based on the SDOH data analysis:

These types of SDOH data insights can help organizations across the healthcare spectrum understand patient health and care needs more holistically, which can improve patient compliance by better addressing patient specific needs. LexisNexis Risk Solutions seeks to advance the value of SDOH data in healthcare and is part of a cross-industry collaborative that developed the guiding principles for use of SDOH data.

Medication adherence tools are essential for healthcare organizations in today's value-based system where nearly three in five1 Americans take at least one daily medication. Non-compliance negatively affects both the health outcomes and healthcare costs. As the prevalence of patients with chronic conditions will continue to increase,2 poor medication adherence costs the U.S. healthcare system at least $100 billion in preventable medical costs annually.3 Non-adherence has significant negative consequences on both patients and providers, including loss of treatment effectiveness and added costs.4 

LexisNexis Risk Solutions Socioeconomic Health Score can provide insights into the key social determinants driving the medication adherence prediction so that healthcare organizations can help connect patients with resources to address their holistic needs. It can be used both independently of other clinical analytics models and in conjunction with existing care management, discharge, and planning platforms. The new predictive score is available in real time via API and in batch format.

To learn more about LexisNexis Socioeconomic Health Scores, click here.  

About LexisNexis Risk Solutions 
LexisNexis® Risk Solutions harnesses the power of data and advanced analytics to provide insights that help businesses and governmental entities reduce risk and improve decisions to benefit people around the globe. We provide data and technology solutions for a wide range of industries including insurance, financial services, healthcare and government. Headquartered in metro Atlanta, Georgia, we have offices throughout the world and are part of RELX (LSE: REL/NYSE: RELX), a global provider of information-based and analytics and decision tools for professional and business customers across industries. For more information, please visit www.risk.lexisnexis.com and www.relx.com.  

References

  1. Accessed via https://www.washingtonpost.com/news/to-your-health/wp/2015/11/03/more-americans-than-ever-are-taking-prescription-drugs/
  2. Accessed via https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876976/
  3. Accessed via https://www.nytimes.com/2017/04/17/well/the-cost-of-not-taking-your-medicine.html  
  4. Accessed via https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055556/

 

SOURCE LexisNexis Risk Solutions


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...



News published on and distributed by: